Professor, Internal Medicine, Yale University School of Medicine
Infectious Disease
Dr. Michael J. Kozal, MD
|
|
Give Review
Dr. Michael J. Kozal works in the field of Infectious Disease. He graduated from University of Nebraska Medical Center. University of Nebraska Medical Center is a top medical college. University of Nebraska Medical Center has a rank of 60 in research and a 4 in primary care Michael J. Kozal has written publications. He has 51 publications published with PubMed. The lastest paper is: 'Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.'
Publications
- Transmission of HIV drug resistance: lessons from sensitive screening assays.
- Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects.
- Deep Sequencing of HIV: Clinical and Research Applications.
- Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure.
- A Study of Financial Incentives to Reduce Plasma HIV RNA Among Patients in Care.
- A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.
- Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.
- Relationship between Minority NNRTI resistance mutations, adherence, and the risk of virologic failure.
- Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.
- Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.
- Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management.
- Raltegravir with unboosted atazanavir 300 mg twice daily in antiretroviral treatment-experienced participants.
- Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.
- Hepatitis C protease and polymerase inhibitors in development.
- Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.
- The hunt for HIV-1 integrase inhibitors.
- A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care.
- HIV drug resistance and HIV transmission risk behaviors among active injection drug users.
- Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naïve Subjects in Hunan Province, China.
- Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing.
- Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study.
- Evolution of genotypic resistance algorithms and their impact on the interpretation of clinical trials: an OPTIMA trial substudy.
- Cross-resistance patterns among HIV protease inhibitors.
- Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before init...
- Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibit...
- Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection.
- Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.
- Does the duration of untreated psychosis affect prognosis in schizophrenia?
- Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.
- Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.
- The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
- Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.
- Using oligonucleotide probe arrays to access genetic diversity.
- HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
- Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.
- A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients.
- Clarification of a method to reverse transcribe human immunodeficiency virus RNA.
- Prevalence of HIV-1 syncytium-inducing phenotype.
- Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA.
- Drug-resistant human immunodefiency virus.
- Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care.
- A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in ...
- Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
- Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
- Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.
- The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral the...
- Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.
- Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as ini...
- Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
- Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care.
Schools
University of Nebraska College of Medicine
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Stanford University -
University of Nebraska Medical Center -
University of Nebraska College of Medicine
Hospital
-
Yale-New Haven Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Margaret K. Fikrig, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vincent A. Andriole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara I. Kazmierczak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaimie P. Meyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nesrine A. Rizk, MD |
|
|
Dr. Alina R. Alfirii, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew H. Grant, MD |
|
|
Dr. Onyema E. Ogbuagu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil Parikh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marwan M. Azar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Anthony Cunningham |